Platelet glycoprotein IIb/IIIa polymorphism HPA-3 b/b is associated with increased risk of ischemic stroke in patients under 60 years of age

Medical Science Monitor

Volumn 18, Issue 1, 2012, Pages

  Dan, Hao ^a   Cai, Yan ^b   Sun, Xiaojiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Glycoprotein IIb IIIa; Ischemic stroke; Platelets; Polymorphism

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; THROMBOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; SMOKING;

EID: 84855323215     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.882195     Document Type: Article

References (29)

1. Lloyd-Jones D, Adams RJ, Brown TM et al: Heart Disease and Stroke Statistics - 2010 Update. A Report From the American Heart Association.Circulation, 2010; 121: e46-e215
2. Adams HP Jr, del Zoppo G, Alberts MJ et al: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, 2007; 115(20): e478-534
3. Padma S, Majaz M: Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset. Arch Med Sci, 2010; 6(3): 303-15
4. Simsek S, Faber NM, Bleeker PM et al: Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA(allele-specific restriction enzyme) analysis. Blood, 1993; 81: 835-40
5. Ingall TJ: Intravenous thrombolysis for acute ischemic stroke: time is prime. Stroke, 2009; 40(6): 2264-65
6. Rwang X, Zhang J, Liu Y et al: Relationship between nerve injury-induced protein gene 2 polymorphism and stroke in Chinese Han population. Biomedical Res, 2011; 25: 11-14
7. Phillips DR, Charo IF, Parise LV et al: The platelet membrane glycoprotein IIb-IIIa complex. Blood, 1988; 71: 831-43
8. Carter AM, Catto AJ, Bamford JM et al: Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke,1999; 30: 2606-11
9. Nurden AT: Polymorphisims of human platelet membrane glycoproteins: structure and clinical significance. Thromb Haemost, 1995; 74: 345-51
10. Hatano S: Experience from a multicentre stroke register. a preliminary report: Bull World Health Organ, 1976; 54(5): 541-53
11. Miller SA, Dykes DD, Polesky HF: Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 1988; 16: 1215
12. Unkelbach K, Kalb R, Santoso S et al: Genomic RFLP typing of human platelet alloantigens Zw(PlA), Ko, Bak and Br (HPA-1,2,3,5). Br J Haematol, 1995; 89: 169-76
13. Reiner AP, Kumar PN, Schwartz SM et al: Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke, 2000; 31: 1628-33
14. Ofosu FA, Nyarko KA: Human platelet thrombin receptors - roles in platelet activation. Hematology, 2000; 14: 1185-98
15. Carlsson LE, Greinacher A, Spitzer C et al: Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke, 1997; 28(7): 1392-95
16. Cater AM, Catto AJ, Bamford JM et al: Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet actibation in acute stroke. Arterioscler Thromb Vasc Biol, 1998; 18: 1124-31
17. Wagner KR, Giles WH, Johoson CJ et al: Platelet glycoprotein receptor IIIa polymorphism PlA2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke, 1998; 29: 581-85
18. Niku KJ, Maarit H, Jussi M et al: Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIa PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival. Stroke, 2007; 38: 50-55
19. Saidi S, Mahjoub T, Slamia LB et al: Polymorphisms of the human platelet alloantigens HPA-1, HPA-2, HPA-3, and HPA-4 in ischemic stroke. Am J Hematol, 2008; 83(7): 570-73
20. Harshad A, Wilbert S. A, Paul L et al: Prevalence of transthoracic echocardiographic abnormalities in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Arch Med Sci, 2010; 6(1): 40-42
21. Cattanen M: Haemorrhagic stroke during anti-platelet therapy. Eur J Anaesthesiol, 2008; 25(Suppl.42): 12-15
22. Christoph K, Miroslava P, Mirko P et al: Targeting platelets in acute experimental stroke. Circulation, 2007; 115: 2323-30
23. Alex AC, Christopher TB, Derk WK et al: Multimodal therapy for the treatment of severae ischemic stroke combining GpIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke, 2005; 36: 2286-88
24. Srivastava P, Moonis M: Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset. Arch Med Sci, 2010; 6(3): 303-15
25. Abciximab Emergent Stroke Treatment Trial Investigators: Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke, 2005; 36: 880-90
26. Seitz RJ, Hamzavi M, Junghans U et al: Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations. Stroke, 2003; 34(8): 1932-35
27. EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med, 1994; 330: 956-61
28. Aguirre FV, Topol EJ, Ferguson JJ et al: Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators. Circulation, 1995; 91: 2882-90
29. Kimouli M, Gourvas V, Konstantoudaki X et al: The effect of an exon 12 polymorphism of the human thromboxane synthase (CYP5A1) gene in stroke patients. Med Sci Monit, 2009; 15(1): BR30-35